Wealth Advisory Solutions’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wealth Advisory Solutions's BMY Position: Q2 2026 in Review
Wealth Advisory Solutions reduced its Bristol-Myers Squibb (BMY) stake by 1.4% in Q2 2026, selling an estimated $8.9K and leaving 10,798 shares worth $622K. The position accounts for 0.13% of the portfolio, ranked #89.
Wealth Advisory Solutions first reported a position in BMY in Q4 2019 and has held it in 15 quarters since. The position peaked at $790K in Q1 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wealth Advisory Solutions held 10,798 shares of Bristol-Myers Squibb worth $622K as of Q2 2026.
- Wealth Advisory Solutions sold 155 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.9K.
- Bristol-Myers Squibb made up 0.13% of Wealth Advisory Solutions's portfolio in Q2 2026, its #89 holding.
- Wealth Advisory Solutions first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 15 quarters since.
- Wealth Advisory Solutions's Bristol-Myers Squibb position peaked at $790K in Q1 2021.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wealth Advisory Solutions's 13F filing for Q2 2026, filed 24 Jul 2026.